Abstract

Although a number of antitumor antibiotics interact with DNA1 to form physical complexes, or covalent adducts with the bases, relatively few damage DNA by specifically interacting with the deoxyribose moiety. Neocarzinostatin (NCS), a member of a family of macromolecular (Mr > 10,000) antibiotics obtained from culture filtrates of Streptomyces, is such an agent (for pertinent literature on NCS prior to 1980, see Ref. 2, and between 1980 and 1984, see Ref. 3). Many of the biochemical and cellular effects of NCS resemble those of ionizing radiation. Most, possibly all, of the DNA lesions caused by NCS appear to result from the direct attack of an activated form of the drug on the deoxyribose of DNA. This is to be contrasted with ionizing radiation or the antibiotic bleomycin, that damage DNA deoxyribose through the intervention of a reduced form of oxygen. This paper will describe current information on the nature of the interaction between the active component of NCS and DNA, on the mechanism of the ensuing deoxyribose damage, and on some of the biological consequences of these actions.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.